OGN Organon & Co.

NYSE
$13.72

Organon & Co. (OGN) is expected to report earnings on October 30, 2026, before the market open. The consensus earnings estimate is $0.95 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on July 31, 2026.

Organon Missed Consensus Estimates
Friday, July 31, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 30
Friday · 7:30 AM ET
Earnings Whisper
-
vs $0.95
Rev est $999
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.62

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Organon & Co.

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.

Sector

Healthcare

Industry

Drug Manufacturers/Other